Redox’s (ASX.RDX) first-quarter fiscal 2027 selling prices were 9% higher than the same time last year, while volumes were flat. Gross profit margin was higher than the 22.4% achieved in fiscal 2026, despite higher freight costs, driven by high oil prices. Intraday Oct. 7, shares were flat.

Why it matters: The first quarter appears to be tracking ahead of our expectations and management’s general targets, but we maintain our forecasts given headwinds from cost-of-living pressure, causing Redox’s customers to require lower quantities of some products.

  • We do not read much into this as sales price, volume, mix, and individual margins of its large product range typically vary over the year. We maintain our fiscal 2027 revenue growth forecast of 6% and gross profit margin estimate of 22%.
  • Our fiscal 2027 estimate assumes cost-of-living pressure results in lower sales volumes than the prior year. Additionally, there were no acquisitions in the past year to add inorganic sales growth. As such, sales growth is from price and low volume growth.

The bottom line: We maintain our fair value estimate of $4.40 for no-moat Redox. Shares trade at a sizable discount of about 21% against our valuation.

  • We think the market is underestimating Redox’s ability to navigate economic cycles. We believe Redox’s exposure to economic cycles is lessened by diversification, serving almost 200 industry subsectors and with more than 1,200 product groups.

Between the lines: Redox’s Chairman, Ian Campbell, retired today at its annual general meeting. New Chair Mary Verschuer has been a director at Redox since 2023 and is also chair of Australian Securities Exchange-listed MaxiParts.

Redox navigates economic weakness with confidence

Redox has achieved a phenomenal revenue CAGR of 10% over the three decades to the end of June 2026, driven by its strategy of diversifying revenue across new product groups, thereby capturing greater market share in the core markets of Australia and New Zealand, and more recently, expanding the business in offshore markets, including Southeast Asia and the United States.

Sourcing from its network of over 1,000 chemical suppliers, Redox continues to expand its product portfolio, with over 5,000 available stock-keeping units across a diverse range of industries and end-customer uses. This one-stop-shop approach supports the firm’s strategy to grow share of spending per customer, leading to above gross domestic product revenue growth.

Redox also expands its customer base via small bolt-on acquisitions of other distributors and introducing them to its expanded product range to grow share of spending. It completed five such transactions over fiscal 2024 and 2025. We expect the company to continue to make small acquisitions in other distributors, thereby providing opportunities to enter new product categories and industry subsectors.

Globally, we expect further expansion to focus on the US. Redox entered North America in 2015, where it has broad geographic coverage. We estimate the US is the world’s second largest chemicals market, after China. But although Redox has had success in winning large volume customers in the US, such as in the beverage industry, we anticipate Redox to remain a small player within these regions. Small and midsize US customers offer better margins, and this is where Redox is seeking to grow market share. We think this will be slow going given the competitive dynamic in the US and estimate group gross margins to ease to historical averages over our 10-year forecast period as its sales are more skewed to lower-margin customers while the business grows in the US.

Bulls say

  • Redox’s sales have historically grown at a rate above gross domestic product, a trend which we expect to persist.
  • As the industry consolidates and smaller companies exit, Redox stands to take market share.
  • Diversity in customers, from almost 200 industry subsectors, shields the firm from the full impact of cyclicality.

Bears say

  • Redox’s contracted sales are exposed to short-term pricing risk from cost changes in chemicals, transportation and handling, and foreign exchange fluctuations.
  • The firm is taking market share through mergers and acquisitions. This exposes the company to the potential of overpaying, eroding returns on invested capital.
  • After almost a decade in the US, this segment remains small, with lower segment gross margins weighing on group margins.

Subscribe to get Morningstar insights in your inbox